Skip to content

Effect of Remote Ischemic Preconditioning on Lung Injury After Pulmonary Resection

Effect of Remote Ischemic Preconditioning on Lung Injury in Patients Undergoing Pulmonary Resection:a Randomised Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01307085
Enrollment
108
Registered
2011-03-02
Start date
2011-02-28
Completion date
2013-06-30
Last updated
2013-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Neoplasms

Keywords

remote ischemic preconditioning, lung injury, pulmonary resection

Brief summary

The purpose of this study is to determine whether ischemic preconditioning reduces lung injury in patients undergoing pulmonary resection.

Detailed description

Remote ischemic preconditioning is an intervention in which brief ischemia of one tissue or organ protects remote organs from a sustained episode of ischemia. It is known that one-lung ventilation in patients undergoing pulmonary resection, which may cause acute lung injury. The investigators did a single-blinded randomised controlled study to establish whether remote ischemic preconditioning reduces lung injury in these patients.

Interventions

PROCEDUREremote ischemic preconditioning

Remote ischaemic preconditioning consisted of three 5-min cycles of right upper limb ischaemia, induced by an automated cuff-inflator placed on the upper arm and inflated to 200 mm Hg, with an intervening 5 min of reperfusion during which the cuff was deflated.

Sponsors

Cai Li
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of pulmonary carcinoma * Must be received pulmonary lobectomy

Exclusion criteria

* Cardiac disease categorized as NYHA classes II-IV * Preoperative severe impairment of respiratory function (arterial oxygen tension (PaO2) \<60 mmHg or FEV1\<50% predicted), * Pre-existing coagulopathy or thrombocytopenia * Prior receipt of chemotherapy or radiation therapy or immunotherapy * Systemic or local active infections (either clinically defined or suggested by evidence such as elevated C-reactive protein levels, leukocytosis, or a body temperature\>38℃) * Peripheral vascular disease affecting the upper limbs * Administration of vitamins, nonsteroidal anti-inflammatory agent or corticosteroid within 3 months.

Design outcomes

Primary

MeasureTime frameDescription
Limb remote ischemic preconditioning has effective protection of lung injury in patients undergoing pulmonary lobectomyJune,2013PaO2/FiO2 in the limb RIPC group was significantly higher than that in the control group at 30 and 60 min after OLV, 30 min and 6 h after operation (all P\<0.05)

Secondary

MeasureTime frameDescription
Cs and CdJune,2013Cs and Cd in limb RIPC group were significantly higher than those in the control group at 30 and 60 min after OLV (all P\<0.05)
IL-6 and TNF-αJune,2013The IL-6 levels in the limb RIPC group were lower than those in the control group at 30 min, 6, 12, 24 and 48 h after operation (all P\<0.05), and there was a significant difference in TNF-α level between the groups (P\<0.01).

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026